On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Adaptive Biotechnologies (United States)

InstitutionResearch output, impact & collaborations

Adaptive Biotechnologies (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Adaptive Biotechnologies (United States)?

ScholarIQrecord summary

Adaptive Biotechnologies (United States) is a research organisation in Seattle, US. OpenAlex records 860 works and 134,804 citations for it. 277 researchers list it as their most recent affiliation.

How many works does Adaptive Biotechnologies (United States) have?

ScholarIQindexed works

Adaptive Biotechnologies (United States) has 860 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Adaptive Biotechnologies (United States) have?

ScholarIQcitation count

Adaptive Biotechnologies (United States) has 134,804 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Adaptive Biotechnologies (United States)?

ScholarIQresearcher count

Adaptive Biotechnologies (United States) has 277 researchers in the ScholarIQ index.

What is the average h-index at Adaptive Biotechnologies (United States)?

ScholarIQavg h-index

Adaptive Biotechnologies (United States) has an average h-index of 58.7 in OpenAlex.

What is the ROR of Adaptive Biotechnologies (United States)?

ScholarIQror

The ROR for Adaptive Biotechnologies (United States) is on the source record.

What is the OpenAlex record for Adaptive Biotechnologies (United States)?

ScholarIQopenalex

The OpenAlex for Adaptive Biotechnologies (United States) is on the source record.

Who are the most-cited researchers behind Adaptive Biotechnologies (United States)?

ScholarIQtop researchers by citations
1
Bryan Howie · Genetic Associations and Epidemiology
84 works52,078 citations
2
Harlan Robins · CAR-T cell therapy research
395 works25,389 citations
3
Ilan R. Kirsch · CAR-T cell therapy research
258 works16,749 citations

What are the most-cited papers on Adaptive Biotechnologies (United States)?

ScholarIQmost cited works
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Douglas B. Johnson, Garrett M. Frampton, Matthew J. Rioth, Erik Yusko, Yaomin Xu, Xingyi Guo, Riley Ennis, David Fabrizio, Zachary R. Chalmers, Joel Greenbowe, Siraj M. Ali, Sohail Balasubramanian, James Sun, Yuting He, Dennie T. Frederick, Igor Puzanov, Justin M. Balko, Justin Cates, Jeffrey S. Ross, Catherine Sanders, Harlan Robins, Yu Shyr, Vincent A. Miller, Philip J. Stephens, Ryan J. Sullivan, Jeffrey A. Sosman, Christine M. Lovly
Cancer Immunology Research. 2016497 CitationsOPEN ACCESS
MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner
Gareth L. Bond, Kim M. Hirshfield, Tomas Kirchhoff, Gabriella Alexe, Elisabeth E. Bond, Harlan Robins, Frank Bartel, Helge Täubert, Peter Wuerl, William N. Hait, Deborah Toppmeyer, Kenneth Offit, Arnold J. Levine
Cancer Research. 2006287 Citations
Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer
Yongwoo David Seo, Xiuyun Jiang, Kevin M. Sullivan, Florencia G. Jalikis, Kimberly S. Smythe, Arezou Abbasi, Marissa Vignali, James O. Park, Sara K. Daniel, Seth M. Pollack, Teresa S. Kim, Raymond S. Yeung, Ian Nicholas Crispe, Robert H. Pierce, Harlan Robins, Venu G. Pillarisetty
Clinical Cancer Research. 2019229 CitationsOPEN ACCESS

How much of the research on Adaptive Biotechnologies (United States) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
0%
Bronze
33%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial